20 Jul Metagenomi Therapeutics
Posted at 20:50h
in
Jian Irish, CEO and President
Oct. 5 | 11:45am | FLW Ballroom F
Emeryville, CA
(NASDAQ: MGX)
Metagenomi is a biotechnology company developing next-generation genome editing technologies to enable curative genetic medicines. Its proprietary metagenomics-based discovery platform identifies and engineers novel gene editing systems designed to expand the range of treatable diseases and improve precision, delivery, and performance. The company is advancing a pipeline of therapeutic programs while also collaborating with industry partners to develop innovative genome editing solutions for patients with serious diseases.